drugset / Trial / NCT02093169
D2 Dopamine Receptor Occupancy After Oral Dosing of Lu AF35700 in Healthy Men Using [11C]-PHNO as Tracer Compound
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To investigate the relationship between the combined Lu AF35700 and Lu AF36152 plasma concentration and D2 dopamine receptor occupancy up to 172 hours after oral dosing of Lu AF35700
Timeline
- Start
- 2014-02
- Primary completion
- 2014-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lu AF35700 | Unknown | 30 mg | Oral |
| Subject | Lu AF35700 | Unknown | 45 mg | Oral |
Indications
No indication recorded.